Jan Johnson

Intel Executive Shares Personal Health Tragicomedy

Eric Dishman discussed his battle with kidney cancer when he keynoted the annual symposium sponsored by the Oregon Medical Association and OCHIN on Wednesday.

Eric Dishman, general manager of Intel's Health Strategy & Solutions Group, told participants at OCHIN and Oregon Medical Association’s annual symposium his “personal health tragicomedy.” It began in 1989 when he was 19, training for a marathon and a student at the University of North Carolin

Health Republic Holds Board Elections, Holds Annual Meeting

Arin Carmack and Kim Lamb were elected to its board of directors.
Health Republic Insurance, a year-old health insurer that calls itself a “true non-profit,” held its inaugural annual meeting and board of directors’ election under a transparent tent in downtown Portland as a symbol of its member-governed structure.

Complaints, Non-Emergent Transportation Focus of Health Share Meeting

On January 1, FamilyCare and Health Share will combine their resources to engage with Access2Care in a contract worth up to $30 million a year.

Health Share reported to its community advisory council in October about member complaints but with no comparable state or national data yet to benchmark against and little beyond the numbers, it’s hard to know where Oregon’s largest coordinated care organization stands.

Adverse Childhood Experiences Misunderstood

Such experiences can play a role not only in a person’s emotional well-being, but their physical health, according to Robert Anda with the CDC.

Can childhood trauma be the central issue affecting health?  Could chemical changes that started in the brain years earlier make people sick not just today but in the future?

Trends from A to W

Consultants share thoughts on what’s happening and what’s coming.

Outpatient care is up, inpatient down, primary care is up, specialists are trending down.  Here’s what three consultants had to say about trends at the State of Reform Conference Wednesday.

New Hepatitis C Drug Could Cost State $690 Million

At the same time, the drug’s manufacturer, Gilead Sciences, had 85.85 percent profits in June and sells the drug much cheaper to other countries.

Taking questions mostly from representatives of pharmaceutical companies at the State of Reform conference, Dr.

Task Force on Public Health Approves Report for Legislature

Rep. Mitch Greenlick, who sat on that task force, believe it’s time to have a modern public health system.

The Task Force on the Future of Public Health approved its “Modernization of Public Health” proposal with minor grammatical changes and one last tweak to language on the social determinants of health.


Subscribe to Jan Johnson